Sivik Global Healthcare LLC Makes New Investment in The Cooper Companies, Inc. $COO

Key Points

• Sivik Global Healthcare LLC has acquired a new position in The Cooper Companies, purchasing 30,000 shares valued at approximately $2.135 million in the second quarter.
• The company's stock buyback program allows for repurchase of up to $2 billion in outstanding shares, signaling potential undervaluation of the stock.
• Cooper Companies reported a quarterly EPS of $1.10, exceeding analysts' expectations and showing 5.7% year-over-year growth in revenue.

Sivik Global Healthcare LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 30,000 shares of the medical device company's stock, valued at approximately $2,135,000.

Other large investors also recently bought and sold shares of the company. Zions Bancorporation National Association UT purchased a new position in Cooper Companies during the 1st quarter worth $33,000. GKV Capital Management Co. Inc. purchased a new position in Cooper Companies during the 1st quarter worth $40,000. Larson Financial Group LLC raised its position in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after buying an additional 664 shares during the last quarter. HM Payson & Co. raised its position in Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after buying an additional 532 shares during the last quarter. Finally, UMB Bank n.a. raised its position in Cooper Companies by 16.7% during the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after buying an additional 129 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Insider Transactions at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius acquired 2,000 shares of the stock in a transaction that occurred on Monday, September 29th. The shares were purchased at an average cost of $68.39 per share, with a total value of $136,780.00. Following the purchase, the director owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Gerard H. Warner III acquired 1,450 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was acquired at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the completion of the purchase, the chief operating officer owned 18,319 shares in the company, valued at $1,268,224.37. The trade was a 8.60% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 17,975 shares of company stock worth $1,216,346 in the last 90 days. Insiders own 1.98% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a research report on Thursday, August 28th. Piper Sandler lowered their price target on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating on the stock in a research note on Thursday, August 28th. Loop Capital set a $100.00 price target on shares of Cooper Companies in a research note on Tuesday, June 17th. Mizuho lowered their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. Finally, BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research note on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $84.75.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $68.37 on Friday. The stock has a market cap of $13.59 billion, a price-to-earnings ratio of 33.68, a PEG ratio of 1.79 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $109.37. The company's 50-day moving average price is $69.43 and its 200 day moving average price is $73.66. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts' consensus estimates of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm's revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has initiated a stock buyback program on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.